Japan’s Nichi-Iko Eyes $65 Million Plant To Compete In Home Generics Market
This article was originally published in PharmAsia News
Executive Summary
Nichi-Iko Pharmaceutical of Japan plans to build a $65 million manufacturing plant to be operational by April 2013, to produce generic drugs for the domestic market.